Meeder Asset Management’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-351
| Closed | -$8K | – | 846 |
|
2022
Q3 | $8K | Buy |
351
+293
| +505% | +$6.68K | ﹤0.01% | 1387 |
|
2022
Q2 | $1K | Buy |
58
+19
| +49% | +$328 | ﹤0.01% | 1972 |
|
2022
Q1 | $1K | Buy |
+39
| New | +$1K | ﹤0.01% | 2135 |
|
2021
Q4 | – | Sell |
-18
| Closed | -$1K | – | 1188 |
|
2021
Q3 | $1K | Hold |
18
| – | – | ﹤0.01% | 2274 |
|
2021
Q2 | $1K | Sell |
18
-27
| -60% | -$1.5K | ﹤0.01% | 2301 |
|
2021
Q1 | $2K | Buy |
45
+27
| +150% | +$1.2K | ﹤0.01% | 2053 |
|
2020
Q4 | $1K | Sell |
18
-4
| -18% | -$222 | ﹤0.01% | 1586 |
|
2020
Q3 | $1K | Buy |
22
+11
| +100% | +$500 | ﹤0.01% | 1918 |
|
2020
Q2 | $0 | Buy |
+11
| New | – | ﹤0.01% | 2036 |
|
2020
Q1 | – | Sell |
-474
| Closed | -$24K | – | 2314 |
|
2019
Q4 | $24K | Sell |
474
-1,257
| -73% | -$63.6K | ﹤0.01% | 1288 |
|
2019
Q3 | $94K | Buy |
+1,731
| New | +$94K | 0.01% | 825 |
|
2019
Q2 | – | Sell |
-43
| Closed | -$1K | – | 2024 |
|
2019
Q1 | $1K | Buy |
+43
| New | +$1K | ﹤0.01% | 1606 |
|